Daiichi Sankyo, Inc. - Exhibitor


 

 

Company Website

Contact Information:

Bill Brum, Jr.
Cell:  904-537-5051
wbrumjr@dsi.com

 

Virtual Exhibit Hall Home

 

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.

Additional Information:

Product Website

Social Media:

Twitter     

LinkedIn

Facebook